{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:29:20Z","timestamp":1774679360378,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ctro.2026.101137","type":"journal-article","created":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T15:22:25Z","timestamp":1771773745000},"page":"101137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Integration of quantitative MRI and liver function indices to predict early tumor response after stereotactic body radiotherapy for hepatocellular carcinoma: A prospective study"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7189-8407","authenticated-orcid":false,"given":"Osamu","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Ohbora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4589-0233","authenticated-orcid":false,"given":"Takuya","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4256-2255","authenticated-orcid":false,"given":"Kousei","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuto","family":"Nakaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7615-3247","authenticated-orcid":false,"given":"Masayuki","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101137_b0005","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101137_b0010","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/0284186X.2013.820342","article-title":"Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients","volume":"53","author":"Sanuki","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctro.2026.101137_b0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ctro.2026.101137_b0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1748-717X-8-249","article-title":"Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters","volume":"8","author":"Jung","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101137_b0025","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1007\/s00330-009-1431-5","article-title":"Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma","volume":"19","author":"Vandecaveye","year":"2009","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ctro.2026.101137_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176118","article-title":"Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma","volume":"12","author":"Oldrini","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ctro.2026.101137_b0035","doi-asserted-by":"crossref","first-page":"14157","DOI":"10.1038\/s41598-019-50503-7","article-title":"Prognostic significance of apparent diffusion coefficient in hepatocellular carcinoma patients treated with stereotactic ablative radiotherapy","volume":"9","author":"Lo","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ctro.2026.101137_b0040","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170118","article-title":"Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma: imaging evaluation post treatment","volume":"91","author":"Kellock","year":"2018","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctro.2026.101137_b0045","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0168-8278(00)00053-2","article-title":"Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status","volume":"34","author":"Trevisani","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.ctro.2026.101137_b0050","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/jhep.2003.50195","article-title":"Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients","volume":"37","author":"Marrero","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ctro.2026.101137_b0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3857\/roj.2021.00934","article-title":"PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy","volume":"40","author":"Cho","year":"2022","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.ctro.2026.101137_b0060","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.21037\/qims-2024-2592","article-title":"Dual-energy computed tomography-derived electron density in the differential diagnosis of focal hepatic lesions: initial experience","volume":"15","author":"Ohtani","year":"2025","journal-title":"Quant Imaging Med Surg"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:25:35Z","timestamp":1774671935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826000327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":12,"alternative-id":["S2405630826000327"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101137","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integration of quantitative MRI and liver function indices to predict early tumor response after stereotactic body radiotherapy for hepatocellular carcinoma: A prospective study","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101137"}}